Health
Health Policy Update
The Trump administration is reportedly considering a plan that could benefit Novo, potentially making drugs more affordable for Medicaid users. However, there are concerns about the potential exceptions to this policy.
Coverage timeline — 2 articles
STAT News
Following successful appeals from drugmakers, the U.K. is taking another look at whether two new Alzheimer's drugs can be considered cost-effective.
2026-03-20 11:05 UTC
STAT News
The White House's GENEROUS plan was designed to make drugs more affordable for Medicaid users. There's one glaring potential exception.
2026-09-22 16:23 UTC